Safety of AV-MEL-1 With Anti-PD-1 Therapy in Metastatic Melanoma

Clinical trial NCT03743298 · UNKNOWN

Trial details

NCT number: NCT03743298
Sponsor: Aivita Biomedical, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2021-04-21
Primary completion: 2024-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.